Literature DB >> 15746262

Nuclear factor kappaB activation in pulmonary leukocytes from infants with hyaline membrane disease: associations with chorioamnionitis and Ureaplasma urealyticum colonization.

Fook-Choe Cheah1, Christine C Winterbourn, Brian A Darlow, Tessa J Mocatta, Margret C M Vissers.   

Abstract

Unresolved pulmonary inflammation in hyaline membrane disease (HMD) may be a precursor to the development of chronic lung disease of early infancy. We investigated whether nuclear factor kappaB (NF-kappaB), a transcription factor that regulates the inflammatory process, is activated in pulmonary leukocytes in tracheal aspirates from premature infants with HMD. A total of 172 samples were obtained from 59 infants, two thirds of whom showed NF-kappaB activation in lung neutrophils and macrophages on at least one occasion. Infants who had activated NF-kappaB showed elevated tumor necrosis factor-alpha concentrations in their tracheal aspirates. These infants also required a longer period of mechanical ventilation support. Almost half of the infants with HMD had antenatal exposure to chorioamnionitis on the basis of placental histopathologic examination. These infants had evidence of activated NF-kappaB and elevated cytokines and were more likely to have Ureaplasma urealyticum colonization in their airways. Together, these observations suggest that NF-kappaB activation in pulmonary leukocytes may be involved in the lung inflammatory process in infants with HMD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15746262     DOI: 10.1203/01.PDR.0000156209.37627.82

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  8 in total

Review 1.  Inflammatory mediators in the immunobiology of bronchopulmonary dysplasia.

Authors:  Rita M Ryan; Qadeer Ahmed; Satyan Lakshminrusimha
Journal:  Clin Rev Allergy Immunol       Date:  2008-04       Impact factor: 8.667

2.  Hyperoxia-induced NF-kappaB activation occurs via a maturationally sensitive atypical pathway.

Authors:  Clyde J Wright; Tiangang Zhuang; Ping La; Guang Yang; Phyllis A Dennery
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-12-12       Impact factor: 5.464

Review 3.  Targeting inflammation to prevent bronchopulmonary dysplasia: can new insights be translated into therapies?

Authors:  Clyde J Wright; Haresh Kirpalani
Journal:  Pediatrics       Date:  2011-06-06       Impact factor: 7.124

Review 4.  Manipulation of gene expression by oxygen: a primer from bedside to bench.

Authors:  Clyde J Wright; Phyllis A Dennery
Journal:  Pediatr Res       Date:  2009-07       Impact factor: 3.756

5.  Experimental amniotic fluid infection in sheep: effects of Ureaplasma parvum serovars 3 and 6 on preterm or term fetal sheep.

Authors:  Timothy J M Moss; Christine L Knox; Suhas G Kallapur; Ilias Nitsos; Christina Theodoropoulos; John P Newnham; Machiko Ikegami; Alan H Jobe
Journal:  Am J Obstet Gynecol       Date:  2008-01       Impact factor: 8.661

6.  Airway inflammatory cell responses to intra-amniotic lipopolysaccharide in a sheep model of chorioamnionitis.

Authors:  Fook-Choe Cheah; J Jane Pillow; Boris W Kramer; Graeme R Polglase; Ilias Nitsos; John P Newnham; Alan H Jobe; Suhas G Kallapur
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-12-31       Impact factor: 5.464

7.  Ureaplasma parvum serovar 3 multiple banded antigen size variation after chronic intra-amniotic infection/colonization.

Authors:  James W Robinson; Samantha J Dando; Ilias Nitsos; John Newnham; Graeme R Polglase; Suhas G Kallapur; J Jane Pillow; Boris W Kramer; Alan H Jobe; Diane Payton; Christine L Knox
Journal:  PLoS One       Date:  2013-04-26       Impact factor: 3.240

Review 8.  Postnatal Infections and Immunology Affecting Chronic Lung Disease of Prematurity.

Authors:  Gloria S Pryhuber
Journal:  Clin Perinatol       Date:  2015-10-01       Impact factor: 3.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.